An explanatory factor analysis of a brief self-report scale to detect neurocognitive impairment among HIV-positive men who have sex with men and transgender women in Peru

References

• Anand, P., Springer, S. A., Copenhaver, M. M., & Altice, F. L. (2010). Neurocognitive impairment and HIV risk factors: A reciprocal relationship. AIDS and Behavior, 14(6), 1213–1226. doi:10.1007/s10461-010-9684-1
   PubMed Web of Science ®Google Scholar
• Bartlet, M. (1954). A note on multiplying factors for various chi-squared approximations. Journal of the Royal Statistical Society, 16, 296–298.
   Google Scholar
• Boisse, L., Gill, M. J., & Power, C. (2008). HIV infection of the central nervous system: Clinical features and neuropathogenesis. Neurologic Clinics, 26(3), 799–819. doi:10.1016/j.ncl.2008.04.002
   PubMed Web of Science ®Google Scholar
• Brown, R. J., Peters, P. J., Caron, C., Gonzalez-Perez, M. P., Stones, L., Ankghuambom, C., … Ball, J. K. (2011). Intercompartmental recombination of HIV-1 contributes to env intrahost diversity and modulates viral tropism and sensitivity to entry inhibitors. Journal of Virology, 85(12), 6024–6037. doi:10.1128/jvi.00131-11
   PubMed Web of Science ®Google Scholar
• Clifford, D. B., & Ances, B. M. (2013). HIV-associated neurocognitive disorder. The Lancet Infectious Diseases, 13(11), 976–986. doi:10.1016/s1473-3099(13)70269-x
   PubMed Web of Science ®Google Scholar
• Copenhaver, M., Shrestha, R., Wickersham, J. A., Weikum, D., & Altice, F. L. (2016). An exploratory factor analysis of a brief self-report scale to detect neurocognitive impairment among participants enrolled in methadone maintenance therapy. The Journal of Substance Abuse Treatment, doi:10.1016/j.jsat.2016.01.002
   PubMed Web of Science ®Google Scholar
• Crum-Cianflone, N. F., Moore, D. J., Letendre, S., Poehlman Roediger, M., Eberly, L., Weintrob, A., … Hale, B. R. (2013). Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons. Neurology, 80(4), 371–379. doi:10.1212/WNL.0b013e31827f0776
   PubMed Web of Science ®Google Scholar
• Ezeabogu, I., Copenhaver, M. M., & Potrepka, J. (2012). The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS. AIDS Care, 24(3), 386–393. doi:10.1080/09540121.2011.608794
   PubMed Web of Science ®Google Scholar
• Ferro, E. G., Weikum, D., Vagenas, P., Copenhaver, M. M., Gonzales, P., Peinado, J., … Altice, F. L. (2014). Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru. AIDS Care, 1–12. doi:10.1080/09540121.2014.963013
   Web of Science ®Google Scholar
• Fialho, R., Pereira, M., Bucur, M., Fisher, M., Whale, R., & Rusted, J. (2016). Cognitive impairment in HIV and HCV co-infected patients: A systematic review and meta-analysis. AIDS Care, 1–14. doi:10.1080/09540121.2016.1191614
   Web of Science ®Google Scholar
• Garcia, P. J., Holmes, K. K., Carcamo, C. P., Garnett, G. P., Hughes, J. P., Campos, P. E., & Whittington, W. L. (2012). Prevention of sexually transmitted infections in urban communities (Peru PREVEN): A multicomponent community-randomised controlled trial. The Lancet, 379(9821), 1120–1128. doi:10.1016/s0140-6736(11)61846-1
   PubMed Web of Science ®Google Scholar
• van Gorp, W. G., Baerwald, J. P., Ferrando, S. J., McElhiney, M. C., & Rabkin, J. G. (1999). The relationship between employment and neuropsychological impairment in HIV infection. Journal of the International Neuropsychological Society, 5(6), 534–539. doi: 10.1017/S1355617799566071
   PubMed Web of Science ®Google Scholar
• Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., & Stefaniak, M. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS, 18(Suppl. 1)), 19–25. doi: 10.1097/00002030-200418001-00004
   PubMed Web of Science ®Google Scholar
• Kahn, J. H. (2006). Factor analysis in counseling psychology research, training, and practice: Principles, advances, and applications. The Counseling Psychologist, 34(5), 684–718. doi:10.1177/0011000006286347
   Web of Science ®Google Scholar
• Kaiser, H. F. (1960). The application of electronic computers to factor analysis. Educational and Psychological Measurement, 20(1), 141–151. doi:10.1177/001316446002000116
   Web of Science ®Google Scholar
• Kaiser, H. F. (1974). An index of factorial simplicity. Psychometrika, 39(1), 31–36. doi:10.1007/BF02291575
   Web of Science ®Google Scholar
• Mind Exchange Working Group. (2013). Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: A consensus report of the mind exchange program. Clinical Infectious Diseases, 56(7), 1004–1017. doi:10.1093/cid/cis975
   PubMed Web of Science ®Google Scholar
• O’Donnell, W. E., De Soto, C. B., & De Soto, J. L. (1993). Validity and reliability of the revised neuropsychological impairment scale (NIS). Journal of Clinical Psychology, 49(3), 372–382. doi: 10.1002/1097-4679(199305)49:3<372::AID-JCLP2270490311>3.0.CO;2-K
   PubMed Web of Science ®Google Scholar
• O’Donnell, W. E., De Soto, C. B., & Desoto, J. R. D. (1994). The neuropsychological impairment scale (NIS) manual. Los Angeles, USA: Western Psychological Services.
   Google Scholar
• O’Donnell, W. E., De Soto, C. B., & Reynolds, D. M. (1984). Sensitivity and specificity of the neuropsychological impairment scale (NIS). Journal of Clinical Psychology, 40(2), 553–555. doi: 10.1002/1097-4679(198403)40:2<553::AID-JCLP2270400229>3.0.CO;2-F
   PubMed Web of Science ®Google Scholar
• O’Donnell, W. E., Reynolds, D. M., & de Soto, C. B. (1983). Neuropsychological impairment scale (NIS): Initial validation study using trailmaking test (A & B) and WAIS digit symbol (scaled score) in a mixed grouping of psychiatric, neurological, and normal patients. Journal of Clinical Psychology, 39(5), 746–748. doi: 10.1002/1097-4679(198309)39:5<746::AID-JCLP2270390517>3.0.CO;2-7
   PubMed Web of Science ®Google Scholar
• O’Donnell, W. E., Reynolds, D. M., & de Soto, C. B. (1984). Validity and reliability of the neuropsychological impairment scale (NIS). Journal of Clinical Psychology, 40(2), 549–553. doi: 10.1002/1097-4679(198403)40:2<549::AID-JCLP2270400228>3.0.CO;2-1
   PubMed Web of Science ®Google Scholar
• Shrestha, R., & Copenhaver, M. (2016). The influence of neurocognitive impairment on HIV risk behaviors and intervention outcomes among high-risk substance users: A systematic review. Front Public Health, 4, 16. doi:10.3389/fpubh.2016.00016
   PubMedGoogle Scholar
• Spudich, S., & Gonzalez-Scarano, F. (2012). HIV-1-related central nervous system disease: Current issues in pathogenesis, diagnosis, and treatment. Cold Spring Harbor Perspectives in Medicine, 2(6), a007120. doi:10.1101/cshperspect.a007120
   PubMed Web of Science ®Google Scholar
• Stern, Y., McDermott, M. P., Albert, S., Palumbo, D., Selnes, O. A., McArthur, J., … Marder, K. S. (2001). Factors associated with incident human immunodeficiency virus-dementia. Archives of Neurology, 58(3), 473–479. doi: 10.1001/archneur.58.3.473
   PubMed Web of Science ®Google Scholar
• Thomas, E. R., Dunfee, R. L., Stanton, J., Bogdan, D., Taylor, J., Kunstman, K., … Gabuzda, D. (2007). Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion. Virology, 360(1), 105–119. doi:10.1016/j.virol.2006.09.036
   PubMed Web of Science ®Google Scholar
• Villa, G., Solida, A., Moro, E., Tavolozza, M., Antinori, A., De Luca, A., … Tamburrini, E. (1996). Cognitive impairment in asymptomatic stages of HIV infection. A longitudinal study. European Neurology, 36(3), 125–133. doi: 10.1159/000117228
   PubMed Web of Science ®Google Scholar